Çolak, S.M.; İlgar, T.; Bahçeci, İ.; Özkaya, E.; Hüner Yiğit, M.; Durmuş, H.; Atiş, F.; Ertürk, A.; Yazıcı, Z.A.
Clinical Significance of Neutralizing Antibodies in COVID-19: Implications for Disease Prognosis. Life 2025, 15, 429.
https://doi.org/10.3390/life15030429
AMA Style
Çolak SM, İlgar T, Bahçeci İ, Özkaya E, Hüner Yiğit M, Durmuş H, Atiş F, Ertürk A, Yazıcı ZA.
Clinical Significance of Neutralizing Antibodies in COVID-19: Implications for Disease Prognosis. Life. 2025; 15(3):429.
https://doi.org/10.3390/life15030429
Chicago/Turabian Style
Çolak, Sudem Mahmutoğlu, Tuba İlgar, İlkay Bahçeci, Esra Özkaya, Merve Hüner Yiğit, Hilal Durmuş, Feyza Atiş, Ayşe Ertürk, and Zihni Acar Yazıcı.
2025. "Clinical Significance of Neutralizing Antibodies in COVID-19: Implications for Disease Prognosis" Life 15, no. 3: 429.
https://doi.org/10.3390/life15030429
APA Style
Çolak, S. M., İlgar, T., Bahçeci, İ., Özkaya, E., Hüner Yiğit, M., Durmuş, H., Atiş, F., Ertürk, A., & Yazıcı, Z. A.
(2025). Clinical Significance of Neutralizing Antibodies in COVID-19: Implications for Disease Prognosis. Life, 15(3), 429.
https://doi.org/10.3390/life15030429